EKF Diagnostics



EKF’s new POC analysers provide lab quality results

 

The Quo-TestŪ and Quo-LabŪ POCT HbA1c analysers from EKF Diagnostics are now available with an integrated connectivity package including a connectivity interface box, cables and a software upgrade, allowing the analyzers to transmit patient data to the majority of Lab Information Management Systems (LIMS) or Hospital Information Systems (HIS) in use today.

The connectivity package uses the POCT1-A2 communication protocol and the in-house designed connectivity interface box to create bidirectional communication between a multitude of Lab Information Management Systems and the Quo systems. Unlike many closed proprietary data management systems, the EKF Diagnostics connectivity solution is open, allowing for easy and simple connection to whatever system the clinic is currently using.

As well as using the industry standard POCT1-A2 communication protocol, the connectivity solution also unlocks a host of new features aimed at improving security and quality control.

Previously it had only been possible to add a patient ID to each test result through use of a barcode scanner, although this process kept the routine simple, transparent and suitable for a global market we found that many hospitals and clinics needed something more. It is now possible to record an increased amount of demographic information including full patient name, date of birth and patient ID numbers using either the standard product barcode scanner or the new keyboard accessory. This additional demographic information enables patient data and their results to be linked and traced throughout the healthcare system. There is also space for additional commentary associated with each result so that other symptoms and observations can be recorded.

As well as patient details, operator IDs can now be added to each test result, significantly improving the traceability and security applied to every HbA1c reading. A controlled list of trained operators assures that only those with sufficient competency have access to the system to start taking measurements. This new feature takes away the risk that an untrained operator can access the system, or even review patient results, unless they have the proper and correct security level.

In addition to these functions, enhanced quality control is now possible with multiple user-defined QC lockout options available to POCT coordinators, ensuring that tests can only be run according to whatever quality assurance procedure is required. Even more traceability is possible as consumables and quality controls can now be added to an approval list meaning only those products that have passed incoming inspection are used.

Lab-quality results
The Quo-TestŪ and Quo-LabŪ offer lab-quality results from just 4 ėL of blood in 4 minutes. Both systems use the interference-free Boronate Fluorescence Quenching Technology (BQFT), which has similar performance to boronate affinity chromatography systems used in reference laboratories but applied in POCT setting.

Traditional clinical methods of testing HbA1c can take a few days to get results back from the laboratory whereas POCT methods allow results to be delivered to the patient almost immediately whilst sat in front of the consulting physician. With the new connectivity package, HbA1c results can also be uploaded to the consulting clinical laboratory meaning not only do healthcare professionals and patients have their results quickly they also have confidence that they have the oversight of interpretation and analysis from qualified clinical biochemists/ POCT coordinators.

Pairing lab quality results with the new connectivity solution takes Quo-TestŪ and Quo-LabŪ to the next level in pointof- care patient management and will help EKF further its aim of making POC diabetes patient management more accessible and robust.

 

 

Date of upload: 15th Mar 2017

                                  
                                               Copyright Đ 2017 MiddleEastHealthMag.com. All Rights Reserved.